{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:13Z","timestamp":1787032873120,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,30]]},"DOI":"10.7759\/cureus.85072","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:27:44Z","timestamp":1748582864000},"source":"Crossref","is-referenced-by-count":2,"title":["A Comprehensive Literature Review of the CDH1 Mutation and Its Role in Gastric Cancer"],"prefix":"10.7759","author":[{"given":"Malik","family":"Samardali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehad","family":"Samardaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Shanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10040163","article-title":"Epidemiology of Helicobacter pylori and CagA-positive infections and global variations in gastric cancer","volume":"10","author":"Park JY","year":"2018","unstructured":"Park JY, Forman D, Waskito LA, Yamaoka Y, Crabtree JE. Epidemiology of Helicobacter pylori and CagA-positive infections and global variations in gastric cancer. Toxins (Basel). 2018, 10:163. 10.3390\/toxins10040163","journal-title":"Toxins (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2024.134840","article-title":"Gastric cancer in Ukraine: epidemiologic data and its nosological structure between","volume":"19","author":"Chernov YO","year":"2024","unstructured":"Chernov YO, Haysanovska V, Makarenko OV. Gastric cancer in Ukraine: epidemiologic data and its nosological structure between. Gastroenterol Rev. 2024, 19:134840. 10.5114\/pg.2024.134840","journal-title":"Gastroenterol Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-015-0474-3","article-title":"A systematic review of laparoscopic total gastrectomy for gastric cancer","volume":"18","author":"Kunisaki C","year":"2015","unstructured":"Kunisaki C, Makino H, Takagawa R, et al.. A systematic review of laparoscopic total gastrectomy for gastric cancer. Gastric Cancer. 2015, 18:218-26. 10.1007\/s10120-015-0474-3","journal-title":"Gastric Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu R","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, et al.. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015, 21:449-56. 10.1038\/nm.3850","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014, 513:202-9. 10.1038\/nature13480","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2016.3473","article-title":"Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes","volume":"48","author":"Kim M","year":"2016","unstructured":"Kim M, Kim JH, Baek SJ, Kim SY, Kim YS. Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes. Int J Oncol. 2016, 48:2497-507. 10.3892\/ijo.2016.3473","journal-title":"Int J Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032848","article-title":"The regulation of cyclins and cyclin-dependent kinases in the development of gastric cancer","volume":"24","author":"Javed A","year":"2023","unstructured":"Javed A, Yarmohammadi M, Korkmaz KS, Rubio-Tom\u00e1s T. The regulation of cyclins and cyclin-dependent kinases in the development of gastric cancer. Int J Mol Sci. 2023, 24:2848. 10.3390\/ijms24032848","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06428.x","article-title":"Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis","volume":"25","author":"Xue H","year":"2010","unstructured":"Xue H, Lin B, Ni P, Xu H, Huang G. Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol. 2010, 25:1604-17. 10.1111\/j.1440-1746.2010.06428.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-102","article-title":"Interleukin-10-819 promoter polymorphism in association with gastric cancer risk","volume":"12","author":"Xue H","year":"2012","unstructured":"Xue H, Lin B, An J, Zhu Y, Huang G. Interleukin-10-819 promoter polymorphism in association with gastric cancer risk. BMC Cancer. 2012, 12:102. 10.1186\/1471-2407-12-102","journal-title":"BMC Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.15430\/JCP.2019.24.3.192","article-title":"\u0392-carotene inhibits expression of c-myc and cyclin E in Helicobacter pylori-infected gastric epithelial cells","volume":"24","author":"Kim D","year":"2019","unstructured":"Kim D, Lim JW, Kim H. \u0392-carotene inhibits expression of c-myc and cyclin E in Helicobacter pylori-infected gastric epithelial cells. J Cancer Prev. 2019, 24:192-6. 10.15430\/JCP.2019.24.3.192","journal-title":"J Cancer Prev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.928195","article-title":"A novel RNA-binding protein-based nomogram for predicting survival of patients with gastric cancer","volume":"27","author":"Zhu M","year":"2021","unstructured":"Zhu M, Cai J, Wu Y, Wu X, Feng L, Yin Z. A novel RNA-binding protein-based nomogram for predicting survival of patients with gastric cancer. Med Sci Monit. 2021, 27:e928195. 10.12659\/MSM.928195","journal-title":"Med Sci Monit"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00847","article-title":"UBE2C is a potential biomarker of intestinal-type gastric cancer with chromosomal instability","volume":"9","author":"Zhang J","year":"2018","unstructured":"Zhang J, Liu X, Yu G, et al.. UBE2C is a potential biomarker of intestinal-type gastric cancer with chromosomal instability. Front Pharmacol. 2018, 9:847. 10.3389\/fphar.2018.00847","journal-title":"Front Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2478\/chilat-2014-0107","article-title":"Mutation in two patients with hereditary gastric cancer","volume":"14","author":"Pogodina J","year":"2014","unstructured":"Pogodina J, Ribenieks R, Berzina D. Mutation in two patients with hereditary gastric cancer. Acta Chirurgica Latviensis. 2014, 14:35-7. 10.2478\/chilat-2014-0107","journal-title":"Acta Chirurgica Latviensis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7150\/jca.10749","article-title":"Complement receptor 1 genetic variants contribute to the susceptibility to gastric cancer in Chinese population","volume":"6","author":"Zhao L","year":"2015","unstructured":"Zhao L, Zhang Z, Lin J, Cao L, He B, Han S, Zhang X. Complement receptor 1 genetic variants contribute to the susceptibility to gastric cancer in Chinese population. J Cancer. 2015, 6:525-30. 10.7150\/jca.10749","journal-title":"J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.6783","article-title":"Association study of single nucleotide polymorphisms in XRCC1 gene with the risk of gastric cancer in Chinese population","volume":"9","author":"Qiao W","year":"2013","unstructured":"Qiao W, Wang T, Zhang L, Tang Q, Wang D, Sun H. Association study of single nucleotide polymorphisms in XRCC1 gene with the risk of gastric cancer in Chinese population. Int J Biol Sci. 2013, 9:753-8. 10.7150\/ijbs.6783","journal-title":"Int J Biol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4238\/gmr.15027828","article-title":"Association between ERCC5 gene polymorphisms and gastric cancer risk","volume":"15","author":"Guo BW","year":"2016","unstructured":"Guo BW, Yang L, Zhao R, Hao SZ. Association between ERCC5 gene polymorphisms and gastric cancer risk. Genet Mol Res. 2016, 15:7828. 10.4238\/gmr.15027828","journal-title":"Genet Mol Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23262","article-title":"Gastric cancer epidemiology and risk factors","volume":"107","author":"Guggenheim DE","year":"2013","unstructured":"Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013, 107:230-6. 10.1002\/jso.23262","journal-title":"J Surg Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317717107","article-title":"Association of NFKB1 and NFKBIA gene polymorphisms with susceptibility of gastric cancer","volume":"39","author":"Li D","year":"2017","unstructured":"Li D, Wu C, Cai Y, Liu B. Association of NFKB1 and NFKBIA gene polymorphisms with susceptibility of gastric cancer. Tumour Biol. 2017, 39:7107. 10.1177\/1010428317717107","journal-title":"Tumour Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5944","article-title":"Prevalence of deleterious ATM germline mutations in gastric cancer patients","volume":"6","author":"Huang DS","year":"2015","unstructured":"Huang DS, Tao HQ, He XJ, et al.. Prevalence of deleterious ATM germline mutations in gastric cancer patients. Oncotarget. 2015, 6:40953-8. 10.18632\/oncotarget.5944","journal-title":"Oncotarget"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004669","article-title":"Germline mutations in MAP3K6 are associated with familial gastric cancer","volume":"10","author":"Gaston D","year":"2014","unstructured":"Gaston D, Hansford S, Oliveira C, et al.. Germline mutations in MAP3K6 are associated with familial gastric cancer. PLoS Genet. 2014, 10:e1004669. 10.1371\/journal.pgen.1004669","journal-title":"PLoS Genet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-009-9316-y","article-title":"Pregnancy after prophylactic total gastrectomy","volume":"9","author":"Kaurah P","year":"2010","unstructured":"Kaurah P, Fitzgerald R, Dwerryhouse S, Huntsman DG. Pregnancy after prophylactic total gastrectomy. Fam Cancer. 2010, 9:331-4. 10.1007\/s10689-009-9316-y","journal-title":"Fam Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-018-0173-8","article-title":"Clinical and functional characterization of the CDH1 germline variant c. 1679C> G in three unrelated families with hereditary diffuse gastric cancer","volume":"26","author":"Pena-Couso L","year":"2018","unstructured":"Pena-Couso L, Perea J, Melo S, et al.. Clinical and functional characterization of the CDH1 germline variant c. 1679C> G in three unrelated families with hereditary diffuse gastric cancer. Eur J Hum Genet. 2018, 26:1348-53. 10.1038\/s41431-018-0173-8","journal-title":"Eur J Hum Genet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2011.01744.x","article-title":"De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer","volume":"82","author":"Shah MA","year":"2012","unstructured":"Shah MA, Salo-Mullen E, Stadler Z, Ruggeri JM, Mirander M, Pristyazhnyuk Y, Zhang L. De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer. Clin Genet. 2012, 82:283-7. 10.1111\/j.1399-0004.2011.01744.x","journal-title":"Clin Genet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-018-0859-1","article-title":"E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function","volume":"22","author":"Godwin TD","year":"2019","unstructured":"Godwin TD, Kelly ST, Brew TP, et al.. E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function. Gastric Cancer. 2019, 22:273-86. 10.1007\/s10120-018-0859-1","journal-title":"Gastric Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/path.1564","article-title":"Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening","volume":"203","author":"Carneiro F","year":"2004","unstructured":"Carneiro F, Huntsman DG, Smyrk TC, et al.. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol. 2004, 203:681-7. 10.1002\/path.1564","journal-title":"J Pathol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2005.031385","article-title":"Cleft lip\/palate and CDH1\/E-cadherin mutations in families with hereditary diffuse gastric cancer","volume":"43","author":"Frebourg T","year":"2006","unstructured":"Frebourg T, Oliveira C, Hochain P, et al.. Cleft lip\/palate and CDH1\/E-cadherin mutations in families with hereditary diffuse gastric cancer. J Med Genet. 2006, 43:138-42. 10.1136\/jmg.2005.031385","journal-title":"J Med Genet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.4612","article-title":"Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer","volume":"31","author":"Corso G","year":"2013","unstructured":"Corso G, Carvalho J, Marrelli D, et al.. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013, 31:868-75. 10.1200\/JCO.2012.44.4612","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S208818","article-title":"CDH1 (E-cadherin) mutation and gastric cancer: genetics, molecular mechanisms and guidelines for management","volume":"11","author":"Shenoy S","year":"2019","unstructured":"Shenoy S. CDH1 (E-cadherin) mutation and gastric cancer: genetics, molecular mechanisms and guidelines for management. Cancer Manag Res. 2019, 11:10477-86. 10.2147\/CMAR.S208818","journal-title":"Cancer Manag Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2019.03.053","article-title":"Multidisciplinary management of CDH1 germinal mutation and prophylactic management hereditary lobular breast cancer: a case report","volume":"58","author":"Mirandola S","year":"2019","unstructured":"Mirandola S, Pellini F, Granuzzo E, et al.. Multidisciplinary management of CDH1 germinal mutation and prophylactic management hereditary lobular breast cancer: a case report. Int J Surg Case Rep. 2019, 58:92-5. 10.1016\/j.ijscr.2019.03.053","journal-title":"Int J Surg Case Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/path.5675","article-title":"Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing","volume":"254","author":"Dixon K","year":"2021","unstructured":"Dixon K, Brew T, Farnell D, et al.. Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing. J Pathol. 2021, 254:254-64. 10.1002\/path.5675","journal-title":"J Pathol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103094","article-title":"Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers","volume":"52","author":"van der Post RS","year":"2015","unstructured":"van der Post RS, Vogelaar IP, Carneiro F, et al.. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015, 52:361-74. 10.1136\/jmedgenet-2015-103094","journal-title":"J Med Genet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S158259","article-title":"Promoter methylation analysis of CDH1 and p14ARF genes in patients with urothelial bladder cancer","volume":"11","author":"Bayramov B","year":"2018","unstructured":"Bayramov B, Gunes S, Buyukalpelli R, Ayd\u0131n O, Henkel R. Promoter methylation analysis of CDH1 and p14ARF genes in patients with urothelial bladder cancer. Onco Targets Ther. 2018, 11:4189-96. 10.2147\/OTT.S158259","journal-title":"Onco Targets Ther"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.197","article-title":"Panel\u00a0testing reveals nonsense and missense CDH1 mutations in families without hereditary diffuse gastric cancer","volume":"4","author":"Huynh JM","year":"2016","unstructured":"Huynh JM, Laukaitis CM. Panel\u00a0testing reveals nonsense and missense CDH1 mutations in families without hereditary diffuse gastric cancer. Mol Genet Genomic Med. 2016, 4:232-6. 10.1002\/mgg3.197","journal-title":"Mol Genet Genomic Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-011-0116-3","article-title":"A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer","volume":"15","author":"Seevaratnam R","year":"2012","unstructured":"Seevaratnam R, Coburn N, Cardoso R, Dixon M, Bocicariu A, Helyer L. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer. Gastric Cancer. 2012, 15:S153-63. 10.1007\/s10120-011-0116-3","journal-title":"Gastric Cancer"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033783","article-title":"E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer","volume":"7","author":"Sim\u00f5es-Correia J","year":"2012","unstructured":"Sim\u00f5es-Correia J, Figueiredo J, Lopes R, Stricher F, Oliveira C, Serrano L, Seruca R. E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer. PLoS One. 2012, 7:e33783. 10.1371\/journal.pone.0033783","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165654","article-title":"CDH1 missense variant C.1679c>g (p.t560r) completely disrupts normal splicing through creation of a novel 5\u2032 splice site","volume":"11","author":"Yelskaya Z","year":"2016","unstructured":"Yelskaya Z, Bacares R, Salo-Mullen E, et al.. CDH1 missense variant C.1679c>g (p.t560r) completely disrupts normal splicing through creation of a novel 5\u2032 splice site. PLoS One. 2016, 11:e0165654. 10.1371\/journal.pone.0165654","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-021-01239-9","article-title":"Integrin \u03b21 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells","volume":"25","author":"Figueiredo J","year":"2022","unstructured":"Figueiredo J, Ferreira RM, Xu H, et al.. Integrin \u03b21 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells. Gastric Cancer. 2022, 25:124-37. 10.1007\/s10120-021-01239-9","journal-title":"Gastric Cancer"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102321","article-title":"Frequency of CDH1 germline mutations in non-gastric cancers","volume":"13","author":"Massari G","year":"2021","unstructured":"Massari G, Magnoni F, Favia G, Peradze N, Veronesi P, La Vecchia C, Corso G. Frequency of CDH1 germline mutations in non-gastric cancers. Cancers (Basel). 2021, 13:2321. 10.3390\/cancers13102321","journal-title":"Cancers (Basel)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/path.4032","article-title":"Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer","volume":"228","author":"Carvalho J","year":"2012","unstructured":"Carvalho J, van Grieken NC, Pereira PM, et al.. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol. 2012, 228:31-44. 10.1002\/path.4032","journal-title":"J Pathol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2023.24.12.4071","article-title":"Methylation status of CDH1 gene in gastric biopsy specimens and its association with H. pylori infection","volume":"24","author":"Hamid KA","year":"2023","unstructured":"Hamid KA, Abdalgalil RS, Mohammed YA, Mahgob R, Mohamedahmed KA, Nour BY. Methylation status of CDH1 gene in gastric biopsy specimens and its association with H. pylori infection. Asian Pac J Cancer Prev. 2023, 24:4071-6. 10.31557\/APJCP.2023.24.12.4071","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-28032010000100002","article-title":"Methylation status of CDH1 gene in samples of gastric mucous from Brazilian patients with chronic gastritis infected by Helicobacter pylori","volume":"47","author":"Kague E","year":"2010","unstructured":"Kague E, Thomazini CM, Pardini MI, Carvalho FD, Leite CV, Pinheiro NA. Methylation status of CDH1 gene in samples of gastric mucous from Brazilian patients with chronic gastritis infected by Helicobacter pylori. Arq Gastroenterol. 2010, 47:7-12. 10.1590\/s0004-28032010000100002","journal-title":"Arq Gastroenterol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.21873\/cgp.20396","article-title":"Copy number variations (CNVs) account for 10.8% of pathogenic variants in patients referred for hereditary cancer testing","volume":"20","author":"Agiannitopoulos K","year":"2023","unstructured":"Agiannitopoulos K, Pepe G, Tsaousis GN, et al.. Copy number variations (CNVs) account for 10.8% of pathogenic variants in patients referred for hereditary cancer testing. Cancer Genomics Proteomics. 2023, 20:448-55. 10.21873\/cgp.20396","journal-title":"Cancer Genomics Proteomics"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1208","article-title":"Comparison of CDH1 penetrance estimates in clinically ascertained families vs families ascertained for multiple gastric cancers","volume":"5","author":"Roberts ME","year":"2019","unstructured":"Roberts ME, Ranola JM, Marshall ML, et al.. Comparison of CDH1 penetrance estimates in clinically ascertained families vs families ascertained for multiple gastric cancers. JAMA Oncol. 2019, 5:1325-31. 10.1001\/jamaoncol.2019.1208","journal-title":"JAMA Oncol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/ph14050457","article-title":"Genetic and epigenetic alterations of CDH1 regulatory regions in hereditary and sporadic gastric cancer","volume":"14","author":"Tedaldi G","year":"2021","unstructured":"Tedaldi G, Molinari C, S\u00e3o Jos\u00e9 C, et al.. Genetic and epigenetic alterations of CDH1 regulatory regions in hereditary and sporadic gastric cancer. Pharmaceuticals (Basel). 2021, 14:457. 10.3390\/ph14050457","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-013-0278-2","article-title":"Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene","volume":"17","author":"Sugimoto S","year":"2014","unstructured":"Sugimoto S, Yamada H, Takahashi M, et al.. Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene. Gastric Cancer. 2014, 17:745-9. 10.1007\/s10120-013-0278-2","journal-title":"Gastric Cancer"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/genes11040391","article-title":"CDH1 mutation distribution and type suggests genetic differences between the etiology of orofacial clefting and gastric cancer","volume":"11","author":"Selvanathan A","year":"2020","unstructured":"Selvanathan A, Nixon CY, Zhu Y, et al.. CDH1 mutation distribution and type suggests genetic differences between the etiology of orofacial clefting and gastric cancer. Genes (Basel). 2020, 11:391. 10.3390\/genes11040391","journal-title":"Genes (Basel)"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-018-1415-5","article-title":"Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series","volume":"16","author":"Gjyshi O","year":"2018","unstructured":"Gjyshi O, Vashi P, Seewald L, et al.. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series. World J Surg Oncol. 2018, 16:143. 10.1186\/s12957-018-1415-5","journal-title":"World J Surg Oncol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.14309\/crj.2016.152","article-title":"Prophylactic total gastrectomy for hereditary diffuse gastric cancer","volume":"3","author":"Shepard B","year":"2016","unstructured":"Shepard B, Yoder L, Holmes C. Prophylactic total gastrectomy for hereditary diffuse gastric cancer. ACG Case Rep J. 2016, 3:e179. 10.14309\/crj.2016.152","journal-title":"ACG Case Rep J"},{"key":"ref49","article-title":"Familial gastric cancer: overview and guidelines for management","volume":"36","author":"Caldas C","year":"1999","unstructured":"Caldas C, Carneiro F, Lynch HT, et al.. Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999, 36:873-80.","journal-title":"J Med Genet"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30219-9","article-title":"Hereditary diffuse gastric cancer: updated clinical practice guidelines","volume":"21","author":"Blair VR","year":"2020","unstructured":"Blair VR, McLeod M, Carneiro F, et al.. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020, 21:e386-97. 10.1016\/S1470-2045(20)30219-9","journal-title":"Lancet Oncol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2020.12.22","article-title":"Deep learning for computer-assisted diagnosis of hereditary diffuse gastric cancer","volume":"55","author":"Rasmussen SA","year":"2021","unstructured":"Rasmussen SA, Arnason T, Huang WY. Deep learning for computer-assisted diagnosis of hereditary diffuse gastric cancer. J Pathol Transl Med. 2021, 55:118-24. 10.4132\/jptm.2020.12.22","journal-title":"J Pathol Transl Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1159\/000514652","article-title":"Diagnosis of MALT lymphoma from surveillance endoscopy of a patient with a CDH1 gene germline mutation","volume":"29","author":"Pinto C","year":"2022","unstructured":"Pinto C, Cunha AL, Rodrigues \u00c2, Dias R, Brand\u00e3o C, Dinis-Ribeiro M. Diagnosis of MALT lymphoma from surveillance endoscopy of a patient with a CDH1 gene germline mutation. GE Port J Gastroenterol. 2022, 29:51-5. 10.1159\/000514652","journal-title":"GE Port J Gastroenterol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-015-2963-4","article-title":"Prophylactic laparoscopic total gastrectomy with jejunal pouch reconstruction in patients carrying a CDH1 germline mutation","volume":"19","author":"Haverkamp L","year":"2015","unstructured":"Haverkamp L, van der Sluis PC, Ausems MG, et al.. Prophylactic laparoscopic total gastrectomy with jejunal pouch reconstruction in patients carrying a CDH1 germline mutation. J Gastrointest Surg. 2015, 19:2120-5. 10.1007\/s11605-015-2963-4","journal-title":"J Gastrointest Surg"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030728","article-title":"Surgery for hereditary diffuse gastric cancer: long-term outcomes","volume":"14","author":"Forrester JD","year":"2022","unstructured":"Forrester JD, Foster D, Ford JM, Longacre TA, Ladabaum U, Fry S, Norton JA. Surgery for hereditary diffuse gastric cancer: long-term outcomes. Cancers (Basel). 2022, 14:728. 10.3390\/cancers14030728","journal-title":"Cancers (Basel)"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.06.009","article-title":"Optimal timing of total gastrectomy to prevent diffuse gastric cancer in individuals with pathogenic variants in CDH1","volume":"18","author":"Laszkowska M","year":"2020","unstructured":"Laszkowska M, Silver ER, Schrope B, Kastrinos F, Wang TC, Hur C. Optimal timing of total gastrectomy to prevent diffuse gastric cancer in individuals with pathogenic variants in CDH1. Clin Gastroenterol Hepatol. 2020, 18:822-9. 10.1016\/j.cgh.2019.06.009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2019.09.062","article-title":"Total gastrectomy for CDH-1 mutation carriers: an institutional experience","volume":"247","author":"DiBrito SR","year":"2020","unstructured":"DiBrito SR, Blair AB, Prasath V, Habibi M, Harmon JW, Duncan MD. Total gastrectomy for CDH-1 mutation carriers: an institutional experience. J Surg Res. 2020, 247:438-44. 10.1016\/j.jss.2019.09.062","journal-title":"J Surg Res"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-14-129","article-title":"Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma","volume":"14","author":"Heitzer E","year":"2013","unstructured":"Heitzer E, Lax S, Lafer I, et al.. Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma. BMC Med Genet. 2013, 14:129. 10.1186\/1471-2350-14-129","journal-title":"BMC Med Genet"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000798","article-title":"Unique challenges of risk-reducing surgery for hereditary diffuse gastric cancer syndrome: a narrative review","volume":"32","author":"Gallanis AF","year":"2023","unstructured":"Gallanis AF, Davis JL. Unique challenges of risk-reducing surgery for hereditary diffuse gastric cancer syndrome: a narrative review. Eur J Cancer Prev. 2023, 32:391-5. 10.1097\/CEJ.0000000000000798","journal-title":"Eur J Cancer Prev"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/ags3.12606","article-title":"Survival outcomes of laparoscopic versus open total gastrectomy with nodal dissection for gastric cancer in a high-volume Japanese center: a propensity score-matched analysis","volume":"7","author":"Kinoshita T","year":"2023","unstructured":"Kinoshita T, Akimoto E, Yura M, Yoshida M. Survival outcomes of laparoscopic versus open total gastrectomy with nodal dissection for gastric cancer in a high-volume Japanese center: a propensity score-matched analysis. Ann Gastroenterol Surg. 2023, 7:53-62. 10.1002\/ags3.12606","journal-title":"Ann Gastroenterol Surg"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1055\/a-1157-8678","article-title":"Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers","volume":"52","author":"van Dieren JM","year":"2020","unstructured":"van Dieren JM, Kodach LL, den Hartog P, et al.. Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers. Endoscopy. 2020, 52:839-46. 10.1055\/a-1157-8678","journal-title":"Endoscopy"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01238","article-title":"Costs of cancer prevention: physical and psychosocial sequelae of risk-reducing total gastrectomy","volume":"42","author":"Gallanis AF","year":"2024","unstructured":"Gallanis AF, Gamble LA, Samaranayake SG, et al.. Costs of cancer prevention: physical and psychosocial sequelae of risk-reducing total gastrectomy. J Clin Oncol. 2024, 42:421-30. 10.1200\/JCO.23.01238","journal-title":"J Clin Oncol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11050-7","article-title":"Predictive model for long-term weight recovery after gastrectomy for gastric cancer: an introduction to a web calculator","volume":"23","author":"Jeon CH","year":"2023","unstructured":"Jeon CH, Park KB, Kim S, Seo HS, Song KY, Lee HH. Predictive model for long-term weight recovery after gastrectomy for gastric cancer: an introduction to a web calculator. BMC Cancer. 2023, 23:580. 10.1186\/s12885-023-11050-7","journal-title":"BMC Cancer"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00300","article-title":"Patients\u2019 medical and psychosocial experiences after detection of a CDH1 variant with multigene panel testing","volume":"3","author":"Hamilton JG","year":"2019","unstructured":"Hamilton JG, Long JM, Brandt AC, et al.. Patients\u2019 medical and psychosocial experiences after detection of a CDH1 variant with multigene panel testing. JCO Precis Oncol. 2019, 3:300. 10.1200\/PO.18.00300","journal-title":"JCO Precis Oncol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i23.2878","article-title":"The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome","volume":"25","author":"Kumar S","year":"2019","unstructured":"Kumar S, Long JM, Ginsberg GG, Katona BW. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome. World J Gastroenterol. 2019, 25:2878-86. 10.3748\/wjg.v25.i23.2878","journal-title":"World J Gastroenterol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-20-430","article-title":"Evaluation of confocal laser endomicroscopy for detection of occult gastric carcinoma in CDH1 variant carriers","volume":"12","author":"Schueler SA","year":"2021","unstructured":"Schueler SA, Gamble LA, Curtin BF, et al.. Evaluation of confocal laser endomicroscopy for detection of occult gastric carcinoma in CDH1 variant carriers. J Gastrointest Oncol. 2021, 12:216-25. 10.21037\/jgo-20-430","journal-title":"J Gastrointest Oncol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112622","article-title":"CDH1 gene mutation hereditary diffuse gastric cancer outcomes: analysis of a large cohort, systematic review of endoscopic surveillance, and secondary cancer risk postulation","volume":"13","author":"Benesch MG","year":"2021","unstructured":"Benesch MG, Bursey SR, O'Connell AC, Ryan MG, Howard CL, Stockley CC, Mathieson A. CDH1 gene mutation hereditary diffuse gastric cancer outcomes: analysis of a large cohort, systematic review of endoscopic surveillance, and secondary cancer risk postulation. Cancers (Basel). 2021, 13:2622. 10.3390\/cancers13112622","journal-title":"Cancers (Basel)"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-020-01749-w","article-title":"Enhanced endoscopic detection of occult gastric cancer in carriers of pathogenic CDH1 variants","volume":"56","author":"Curtin BF","year":"2021","unstructured":"Curtin BF, Gamble LA, Schueler SA, et al.. Enhanced endoscopic detection of occult gastric cancer in carriers of pathogenic CDH1 variants. J Gastroenterol. 2021, 56:139-46. 10.1007\/s00535-020-01749-w","journal-title":"J Gastroenterol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i33.5595","article-title":"Gastric cancer mortality related to direct radiographic and endoscopic screening: a retrospective study","volume":"27","author":"Hagiwara H","year":"2021","unstructured":"Hagiwara H, Moki F, Yamashita Y, Saji K, Iesaki K, Suda H. Gastric cancer mortality related to direct radiographic and endoscopic screening: a retrospective study. World J Gastroenterol. 2021, 27:5595-609. 10.3748\/wjg.v27.i33.5595","journal-title":"World J Gastroenterol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/srep25798","article-title":"Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression","volume":"6","author":"Pan Y","year":"2016","unstructured":"Pan Y, Li J, Zhang Y, et al.. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression. Sci Rep. 2016, 6:25798. 10.1038\/srep25798","journal-title":"Sci Rep"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1197-5","article-title":"Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer","volume":"15","author":"Chen I","year":"2017","unstructured":"Chen I, Mathews-Greiner L, Li D, et al.. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. J Transl Med. 2017, 15:92. 10.1186\/s12967-017-1197-5","journal-title":"J Transl Med"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1177\/0300891620949668","article-title":"Overview on new progress of hereditary diffuse gastric cancer with CDH1 variants","volume":"106","author":"Hu MN","year":"2020","unstructured":"Hu MN, Hu SH, Zhang XW, Xiong SM, Deng H. Overview on new progress of hereditary diffuse gastric cancer with CDH1 variants. Tumori. 2020, 106:346-55. 10.1177\/0300891620949668","journal-title":"Tumori"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300050","article-title":"Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer","volume":"61","author":"Shimada S","year":"2012","unstructured":"Shimada S, Mimata A, Sekine M, et al.. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer. Gut. 2012, 61:344-53. 10.1136\/gutjnl-2011-300050","journal-title":"Gut"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/s11670-012-0023-0","article-title":"Caveolin-1, E-cadherin and \u03b2-catenin in gastric carcinoma, precancerous tissues and chronic non-atrophic gastritis","volume":"24","author":"Sun GY","year":"2012","unstructured":"Sun GY, Wu JX, Wu JS, Pan YT, Jin R. Caveolin-1, E-cadherin and \u03b2-catenin in gastric carcinoma, precancerous tissues and chronic non-atrophic gastritis. Chin J Cancer Res. 2012, 24:23-8. 10.1007\/s11670-012-0023-0","journal-title":"Chin J Cancer Res"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2096","article-title":"High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk","volume":"12","author":"Maekita T","year":"2006","unstructured":"Maekita T, Nakazawa K, Mihara M, et al.. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 2006, 12:989-95. 10.1158\/1078-0432.CCR-05-2096","journal-title":"Clin Cancer Res"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.8308","article-title":"Pizotifen inhibits the proliferation and invasion of gastric cancer cells","volume":"19","author":"Jiang Y","year":"2020","unstructured":"Jiang Y, Wang W, Wu X, Shi J. Pizotifen inhibits the proliferation and invasion of gastric cancer cells. Exp Ther Med. 2020, 19:817-24. 10.3892\/etm.2019.8308","journal-title":"Exp Ther Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2010.01564.x","article-title":"Periodontal disease progression and glycaemic control among Gullah African Americans with type-2 diabetes","volume":"37","author":"Bandyopadhyay D","year":"2010","unstructured":"Bandyopadhyay D, Marlow NM, Fernandes JK, Leite RS. Periodontal disease progression and glycaemic control among Gullah African Americans with type-2 diabetes. J Clin Periodontol. 2010, 37:501-9. 10.1111\/j.1600-051X.2010.01564.x","journal-title":"J Clin Periodontol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-024-01504-7","article-title":"CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions","volume":"27","author":"Herrera-Pariente C","year":"2024","unstructured":"Herrera-Pariente C, Bonjoch L, Mu\u00f1oz J, et al.. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions. Gastric Cancer. 2024, 27:747-59. 10.1007\/s10120-024-01504-7","journal-title":"Gastric Cancer"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071609","article-title":"E-cadherin-deficient cells are sensitive to the multikinase inhibitor dasatinib","volume":"14","author":"Bougen-Zhukov N","year":"2022","unstructured":"Bougen-Zhukov N, Decourtye-Espiard L, Mitchell W, et al.. E-cadherin-deficient cells are sensitive to the multikinase inhibitor dasatinib. Cancers (Basel). 2022, 14:1609. 10.3390\/cancers14071609","journal-title":"Cancers (Basel)"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2023244","article-title":"Upregulation of E-cadherin by the combination of methionine restriction and HDAC2 intervention for inhibiting gastric carcinoma metastasis","volume":"56","author":"Li Y","year":"2024","unstructured":"Li Y, Liu C, Xin L, et al.. Upregulation of E-cadherin by the combination of methionine restriction and HDAC2 intervention for inhibiting gastric carcinoma metastasis. Acta Biochim Biophys Sin (Shanghai). 2024, 56:62-70. 10.3724\/abbs.2023244","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1941-0","article-title":"Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing","volume":"17","author":"Cai H","year":"2019","unstructured":"Cai H, Jing C, Chang X, et al.. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. J Transl Med. 2019, 17:189. 10.1186\/s12967-019-1941-0","journal-title":"J Transl Med"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-018-0184-7","article-title":"Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk","volume":"7","author":"Li D","year":"2018","unstructured":"Li D, Lo W, Rudloff U. Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk. Clin Transl Med. 2018, 7:7. 10.1186\/s40169-018-0184-7","journal-title":"Clin Transl Med"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091359","article-title":"Allosteric AKT inhibitors target synthetic lethal vulnerabilities in E-cadherin-deficient cells","volume":"11","author":"Bougen-Zhukov N","year":"2019","unstructured":"Bougen-Zhukov N, Nouri Y, Godwin T, et al.. Allosteric AKT inhibitors target synthetic lethal vulnerabilities in E-cadherin-deficient cells. Cancers (Basel). 2019, 11:1359. 10.3390\/cancers11091359","journal-title":"Cancers (Basel)"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000688","article-title":"CDH1 germline mutations in families with hereditary lobular breast cancer","volume":"31","author":"Girardi A","year":"2022","unstructured":"Girardi A, Magnoni F, Vicini E, Kouloura A, La Vecchia C, Veronesi P, Corso G. CDH1 germline mutations in families with hereditary lobular breast cancer. Eur J Cancer Prev. 2022, 31:274-8. 10.1097\/CEJ.0000000000000688","journal-title":"Eur J Cancer Prev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/369542-a-comprehensive-literature-review-of-the-cdh1-mutation-and-its-role-in-gastric-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:27:45Z","timestamp":1748582865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/369542-a-comprehensive-literature-review-of-the-cdh1-mutation-and-its-role-in-gastric-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":83,"URL":"https:\/\/doi.org\/10.7759\/cureus.85072","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}